J. Decroix

1.0k total citations
29 papers, 764 citations indexed

About

J. Decroix is a scholar working on Dermatology, Epidemiology and Rheumatology. According to data from OpenAlex, J. Decroix has authored 29 papers receiving a total of 764 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Dermatology, 12 papers in Epidemiology and 4 papers in Rheumatology. Recurrent topics in J. Decroix's work include Nail Diseases and Treatments (10 papers), Dermatology and Skin Diseases (5 papers) and Cutaneous lymphoproliferative disorders research (5 papers). J. Decroix is often cited by papers focused on Nail Diseases and Treatments (10 papers), Dermatology and Skin Diseases (5 papers) and Cutaneous lymphoproliferative disorders research (5 papers). J. Decroix collaborates with scholars based in Belgium, Germany and France. J. Decroix's co-authors include Gérald Pierard, A. Bibby, W.S. Douglas, Véronique Goffin, C Piérard-Franchimont, Ulrich Mrowietz, M. Heenen, F. Cambazard, D. Lowson and A.C. Chu and has published in prestigious journals such as Journal of the American Academy of Dermatology, Journal of the European Academy of Dermatology and Venereology and Acta Dermato Venereologica.

In The Last Decade

J. Decroix

27 papers receiving 696 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
J. Decroix Belgium 14 412 322 302 139 102 29 764
Steven E. Prawer United States 14 406 1.0× 310 1.0× 197 0.7× 22 0.2× 80 0.8× 23 825
Esra Adışen Türkiye 16 429 1.0× 192 0.6× 196 0.6× 75 0.5× 86 0.8× 73 711
Ömer Çalka Türkiye 14 299 0.7× 113 0.4× 75 0.2× 101 0.7× 83 0.8× 88 726
Margaret Song South Korea 15 336 0.8× 119 0.4× 174 0.6× 59 0.4× 90 0.9× 46 574
Sara Moradi Tuchayi United States 14 608 1.5× 137 0.4× 164 0.5× 94 0.7× 38 0.4× 32 881
Dimitris Rigopoulos Greece 14 403 1.0× 201 0.6× 155 0.5× 61 0.4× 144 1.4× 41 680
Tahir Saeed Haroon Pakistan 17 317 0.8× 370 1.1× 69 0.2× 264 1.9× 132 1.3× 59 900
Kıymet Baz Türkiye 12 357 0.9× 89 0.3× 138 0.5× 47 0.3× 45 0.4× 27 688
Arijit Coondoo India 10 437 1.1× 112 0.3× 75 0.2× 46 0.3× 57 0.6× 22 633
Muhterem Polat Türkiye 12 235 0.6× 102 0.3× 75 0.2× 69 0.5× 31 0.3× 40 420

Countries citing papers authored by J. Decroix

Since Specialization
Citations

This map shows the geographic impact of J. Decroix's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J. Decroix with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J. Decroix more than expected).

Fields of papers citing papers by J. Decroix

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J. Decroix. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J. Decroix. The network helps show where J. Decroix may publish in the future.

Co-authorship network of co-authors of J. Decroix

This figure shows the co-authorship network connecting the top 25 collaborators of J. Decroix. A scholar is included among the top collaborators of J. Decroix based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J. Decroix. J. Decroix is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Decroix, J., et al.. (2006). Desloratadine 5 mg once daily improves the quality of life of patients with chronic idiopathic urticaria. Journal of the European Academy of Dermatology and Venereology. 20(3). 288–292. 24 indexed citations
2.
Decroix, J., et al.. (2004). Clobetasol propionate lotion in the treatment of moderate to severe plaque-type psoriasis.. PubMed. 74(3). 201–6. 17 indexed citations
3.
Douglas, W.S., Yves Poulin, J. Decroix, et al.. (2002). A New Calcipotriol/Betamethasone Formulation with Rapid Onset of Action was Superior to Monotherapy with Betamethasone Dipropionate or Calcipotriol in Psoriasis Vulgaris. Acta Dermato Venereologica. 82(2). 131–135. 121 indexed citations
4.
Piérard-Franchimont, C, Véronique Goffin, J. Decroix, & Gérald Pierard. (2002). A Multicenter Randomized Trial of Ketoconazole 2% and Zinc Pyrithione 1% Shampoos in Severe Dandruff and Seborrheic Dermatitis. Skin Pharmacology and Physiology. 15(6). 434–441. 69 indexed citations
5.
Kaufmann, Roland, A. Bibby, Robert Bissonnette, et al.. (2002). A New Calcipotriol/Betamethasone Dipropionate Formulation (Daivobet<sup>TM</sup>) Is an Effective Once-Daily Treatment for Psoriasis vulgaris. Dermatology. 205(4). 389–393. 127 indexed citations
6.
Decroix, J., et al.. (2000). Short-term itraconazole versus terbinafine in the treatmentof superficial dermatomycosis of the glabrous skin(tinea corporis or cruris). European Journal of Dermatology. 7(5). 353–357. 3 indexed citations
7.
Tausch, I, et al.. (1998). Short‐term itraconazole versus terbinafine in the treatment of tinea pedis or manus. International Journal of Dermatology. 37(2). 140–142. 30 indexed citations
8.
Gupta, Aditya K., Piet De Doncker, Annie Heremans, et al.. (1997). Itraconazole for the treatment of tinea pedis: A dosage of 400 mg/day given for 1 week is similar in efficacy to 100 or 200 mg/day given for 2 to 4 weeks. Journal of the American Academy of Dermatology. 36(5). 789–792. 23 indexed citations
9.
Scher, Richard K., Robert Baran, J. Decroix, et al.. (1997). Itraconazole therapy is effective for pedal onychomycosis caused by some nondermatophyte molds and in mixed infection with dermatophytes and molds: A multicenter study with 36 patients. Journal of the American Academy of Dermatology. 36(2). 173–177. 85 indexed citations
10.
Parent, Dominique, J. Decroix, & M. Heenen. (1994). Clinical Experience with Short Schedules of Itraconazole in the Treatment of Tinea corporis and/or Tinea cruris. Dermatology. 189(4). 378–381. 29 indexed citations
11.
Marcoux, C., André Bourlond, & J. Decroix. (1991). [Angiolymphoid Hyperplasia With Eosinophilia - Remission Sous Acitretine - Remission With Acitretin]. Annales de Dermatologie et de Vénéréologie. 118(3). 217–221. 1 indexed citations
12.
Marcoux, C., A Bourlond, & J. Decroix. (1991). [Angiolymphoid hyperplasia with eosinophilia. Remission with acitretin].. PubMed. 118(3). 217–21. 9 indexed citations
13.
Bourlond, A, et al.. (1989). Double‐Blind Comparison of Itraconazole with Griseofulvin in the Treatment of Tinea Corporis and Tinea Cruris. International Journal of Dermatology. 28(6). 410–412. 45 indexed citations
14.
Decroix, J., et al.. (1989). [A new case of Goltz's syndrome].. PubMed. 116(10). 715–8. 1 indexed citations
15.
Decroix, J., et al.. (1989). Hamartome fibreux de Enzinger. Dermatology. 179(3). 149–153. 1 indexed citations
16.
Decroix, J., et al.. (1988). [Buschke-Ollendorff syndrome. 6 cases in one family].. PubMed. 115(4). 455–8. 2 indexed citations
17.
Decroix, J., et al.. (1987). [Gougerot-Carteaud confluent and reticulated papillomatosis associated with pseudoacanthosis nigricans: the same entity?].. PubMed. 114(2). 223–6. 5 indexed citations
18.
Kint, A, et al.. (1985). [Congenital hypertrichosis lanuginosa].. PubMed. 36(7). 423–4. 3 indexed citations
19.
Decroix, J., et al.. (1981). Balanite circonscrite chronique. Dermatology. 162(5). 362–367. 1 indexed citations
20.
Mar�chal, G., et al.. (1981). The uncombable hair syndrome four non-familial cases of pili trianguli et canaliculi. Archives of Dermatological Research. 271(2). 223–227. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026